Form 4: XOMA Royalty Corp. Director Barbara Kosacz Receives Equity Grant of Restricted Stock Units

XOMA Royalty Corp. Director Barbara Kosacz was granted 5,971 restricted stock units, which will vest on the first anniversary of the grant date, aligning her interests with the company's long-term performance.

Summary

• Barbara Kosacz, a Director of XOMA Royalty Corp. (XOMA), acquired 5,971 shares of common stock on May 21, 2025.
• These shares were granted in the form of Restricted Stock Units (RSUs), with an acquisition price of $0 per unit.
• Each RSU represents the right to receive one share of common stock of the Company upon settlement.
• The RSUs are scheduled to vest on the first anniversary of the grant date, which is May 21, 2026.
• Vesting is contingent upon Ms. Kosacz's continued service to XOMA Royalty Corp. through the vesting date.
• Following this transaction, Ms. Kosacz directly beneficially owns 5,971 shares of common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive step for aligning management incentives with shareholder interests and promoting long-term retention, though it does not directly impact immediate operational or financial performance.

Positives

• The grant of 5,971 Restricted Stock Units (RSUs) to Director Barbara Kosacz aligns her financial interests directly with the long-term performance and shareholder value of XOMA Royalty Corp.
• The vesting schedule, tied to continued service, promotes retention of key management personnel and encourages long-term commitment to the company's success.

Negatives

• NA

Risks

• The vesting of the 5,971 Restricted Stock Units is subject to the reporting person's continued service to the Company through the vesting date; if service ceases before vesting, the RSUs may be forfeited.

Future Outlook

The 5,971 Restricted Stock Units granted to Director Barbara Kosacz are expected to vest on May 21, 2026, contingent upon her continued service to XOMA Royalty Corp. through that date.

Management Comments

• NA

Industry Context

This Form 4 filing represents a routine disclosure of an insider equity grant, which is a common practice across various industries, including biotechnology and royalty acquisition, to compensate directors and align their long-term interests with those of the company's shareholders.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The grant of equity to a director can enhance alignment between management and shareholder interests, potentially leading to more focused long-term value creation.
• Employees: No direct impact on general employees is mentioned in this specific filing.

Next Steps

• The 5,971 Restricted Stock Units are expected to vest on May 21, 2026, subject to Barbara Kosacz's continued service to the company.

Key Dates

Keywords

XOMA Royalty Corp, XOMA, Form 4, SEC filing, insider transaction, restricted stock units, RSU, equity grant, director compensation, beneficial ownership